|
Federal Register
Notices
> Notice of Registration - 2009
>
Halo Pharmaceutical Inc
FR Doc E9-2538[Federal Register: February 6, 2009 (Volume 74, Number 24)]
[Notices] [Page 6311] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06fe09-85]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated October 7, 2008 and published in the Federal Register on
October 14, 2008, (73 FR 60719), Halo Pharmaceutical Inc., 30 North Jefferson
Road, Whippany, New Jersey 07981, made application to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the basic
classes of controlled substances listed in schedules I and II:
|
Drug
|
Schedule
|
|
Dihydromorphine (9145)
|
I
|
|
Hydromorphone (9150)
|
II
|
Dihydromorphine is an intermediate in the manufacture of Hydromorphone and is
not for commercial distribution. The company plans to manufacture Hydromorphone
HCL for sale to other manufacturers and for the manufacture of other controlled
substance dosage units for distribution to its customers.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Halo Pharmaceutical
Inc. to manufacture the listed basic classes of controlled substances is
consistent with the public interest at this time. DEA has investigated Halo
Pharmaceutical Inc. to ensure that the company's registration is consistent with
the public interest. The investigation has included inspection and testing of
the company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's background
and history. Therefore, pursuant to 21
U.S.C. 823, and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: January 30, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-2538 Filed 2-5-09; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|